Observations from ID and Beyond: Long-Acting Injectable HIV Therapy for People Who Won't Take ART?

In HIV and ID Observations, Dr. Paul Sax discusses an option for patients who can't, or won't, take oral antiretroviral therapy.

In the latest HIV and ID Observations, Dr. Paul Sax talks about a case series in which patients with uncontrolled HIV not on suppressive antiretroviral therapy received long-acting cabotegravir and rilpivirine.

Do you want to be notified whenever Dr. Sax posts? Sign up to receive notifications by email by using the Subscribe box.

Want to see more from NEJM Journal Watch? Register here.

Observations from ID and Beyond: Long-Acting Injectable HIV Therapy for People Who Won't Take ART?

Topics